EU CMO market to top $20bn as big pharma ups outsourcing
A patent loss-fuelled surge in big pharma outsourcing will push the European CMO market through the $20bn barrier by 2018, analysis claims.
Archives for January 25, 2012
An experienced CMO is key to successful biologics development says Cobra Biologics
Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.
Vivalis grows sales as demand for vaccine cell line increases
Vivalis nearly doubled revenues from its vaccine production platform in 2011 and has inked a third mAb discovery programme with Sanofi.